Evidence map›Paper›PMID 28527919›Full record

ReviewPharmacology & therapeutics2017

Mechanisms of the amplifying pathway of insulin secretion in the β cell.

Michael A Kalwat, Melanie H Cobb

Open access · greenAbstract readReview
In one paragraph

Review in Pharmacology & therapeutics, 2017. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 88 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
88citing papers in PubMed, 1 pooled it
9.7field-weighted citation impact, top 1% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

88 citing papers in PubMed, 1 synthesis or guideline pooled it, 147 citations in OpenAlex.

  1. Pooled it
  2. Review
  3. Article
  4. Review
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Observational
  14. Article
  15. Article
  16. Review
  17. Article
  18. Review
  19. The MODY-associatedeLife · 2024
    Article
  20. Article

28 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

2 authors at 1 institution in 1 country.

Michael A KalwatDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, United States. Electronic address: Michael.Kalwat@utsouthwestern.edu.
Melanie H CobbDepartment of Pharmacology, University of Texas Southwestern Medical Center, Dallas, TX, United States.
The University of Texas Southwestern Medical Center · US

Funding

Insulin-Regulated MAP Kinase PathwaysR37DK034128 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 2007 to 2016
$5.1M
MAP Kinse in Islet FunctionR01DK055310 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H. · 1998 to 2014
$3.4M
INSULIN-REGULATED MAP KINASE PATHWAYSR01DK034128 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI COBB, MELANIE H · 1986 to 2006
$2.4M
Role of isoxazole compounds in beta cell differentiation and functionF32DK100113 · NIDDK · UT SOUTHWESTERN MEDICAL CENTER · PI KALWAT, MICHAEL ANDREW · 2013 to 2016
$161k
NIDDK NIH HHS F32 DK100113NIDDK NIH HHS R01 DK034128NIDDK NIH HHS R01 DK055310NIDDK NIH HHS R37 DK034128
6 · The paper itself

Abstract

Pancreatic islet β cells secrete insulin in response to nutrient secretagogues, like glucose, dependent on calcium influx and nutrient metabolism. One of the most intriguing qualities of β cells is their ability to use metabolism to amplify the amount of secreted insulin independent of further alterations in intracellular calcium. Many years studying this amplifying process have shaped our current understanding of β cell stimulus-secretion coupling; yet, the exact mechanisms of amplification have been elusive. Recent studies utilizing metabolomics, computational modeling, and animal models have progressed our understanding of the metabolic amplifying pathway of insulin secretion from the β cell. New approaches will be discussed which offer in-roads to a more complete model of β cell function. The development of β cell therapeutics may be aided by such a model, facilitating the targeting of aspects of the metabolic amplifying pathway which are unique to the β cell.

Indexed as

AnimalsGlucoseHumansInsulinInsulin-Secreting CellsInsulin SecretionMetabolomicsSignal TransductionGlucoseInsulinAmplifying pathwayBiphasic insulin secretionCell signalingGlucose sensingMetabolomicsPancreatic islet beta cells

Identifiers

PMID28527919
PMCPMC7269041
OpenAlexW2616259547

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.